✦ LIBER ✦

Effect of BRAF V600E mutation on tumor response of anti-EGFR monoclonal antibodies for first-line metastatic colorectal cancer treatment: a meta-analysis of randomized studies

✍ Scribed by Cui, Dandan; Cao, Dan; Yang, Yu; Qiu, Meng; Huang, Ying; Yi, Cheng

Book ID: 121472261
Publisher: Springer
Year: 2014
Tongue: English
Weight: 330 KB
Volume: 41
Category: Article
ISSN: 0301-4851
DOI: 10.1007/s11033-013-2974-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EGFRgene copy number as a predictive bio

EGFRgene copy number as a predictive biomarker for the treatment of metastatic colorectal cancer with anti-EGFR monoclonal antibodies: a meta-analysis

✍ Zu-Yao Yang, Wei-Xi Shen, Xue-Feng Hu, Da-Yong Zheng, Xin-Yin Wu, Ya-Fang Huang, 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 368 KB

Cetuximab Plus Irinotecan, Fluorouracil,

Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status

✍ Van Cutsem, E.; Kohne, C.-H.; Lang, I.; Folprecht, G.; Nowacki, M. P.; Cascinu, 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 219 KB

6077 A meta-analysis of the CRYSTAL and

6077 A meta-analysis of the CRYSTAL and OPUS studies combining cetuximab with chemotherapy (CT) as 1st-line treatment for patients (pts) with metastatic colorectal cancer (mCRC): Results according to KRAS and BRAF mutation status

✍ Van Cutsem, E.; Rougier, P.; Köhne, C.; Stroh, C.; Schlichting, M.; Bokemeyer, C 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB